Articles | EuroIntervention

10.4244/EIJV9I11A224 • Mar 20, 2014

Novel oral anticoagulants in acute coronary syndrome: re-evaluating the thrombin hypothesis

Bassand J-P

free

10.4244/EIJV9I11A225 • Mar 20, 2014

Updating the evidence on patent foramen ovale closure versus medical therapy in patients with cryptogenic stroke: a systematic review and comprehensive meta-analysis of 2,303 patients from three randomised trials and 2,231 patients from 11 observational studies

Capodanno D, Milazzo G, Vitale L, Di Stefano D, Di Salvo M, Grasso C, Tamburino C

free

10.4244/EIJV9I11A226 • Mar 20, 2014

Cangrelor versus clopidogrel in percutaneous coronary intervention: a systematic review and meta-analysis

Pandit A, Aryal M, Pandit A, Jalota L, Hakim F, Mookadam F, Lee H, Tleyjeh I

free

10.4244/EIJV9I11A227 • Mar 20, 2014

Tools and Techniques - Clinical: Paravalvular leak closure

Gafoor S, Steinberg D, Franke J, Bertog S, Vaskelyte L, Hofmann I, Sievert H

free

10.4244/EIJV9I11A228 • Mar 20, 2014

How should I treat a coronary bifurcation wide-neck aneurysm?

Sgueglia G, Santarelli A, Cianni R, Pucci E

free

10.4244/EIJV9I11A229 • Mar 20, 2014

First-in-man Portico® transcatheter aortic valve-in-valve implantation in a degenerated 19 mm Mitroflow® aortic pericardial heart valve

Jeger RV, Manoharan G, Kaiser C

free

10.4244/EIJV9I10A191 • Feb 20, 2014

Surgical or transcatheter mitral valve intervention: complex disease requires complex decisions

Head S, van Leeuwen W, Van Mieghem NM, Kappetein A

free

10.4244/EIJV9I10A192 • Feb 20, 2014

Cardiac conduction disturbances after transcatheter aortic valve replacement: much remains to be learned

Nazif TM, Kodali SK

free

10.4244/EIJV9I10A193 • Feb 20, 2014

Chronic total coronary occlusion percutaneous intervention

Reifart N

free

• Feb 20, 2014

EAPCI Focus on the Turkish Society of Cardiology Association of Percutaneous Cardiovascular Interventions (TAPCI-TSC)

free

10.4244/EIJV9I10A194 • Feb 20, 2014

Occurrence, fate and consequences of ventricular conduction abnormalities after transcatheter aortic valve implantation

Houthuizen P, van der Boon R, Urena M, Van Mieghem NM, Brueren G, Poels T, Van Garsse L, Rodés-Cabau J, Prinzen F, de Jaegere P

free

10.4244/EIJV9I10A195 • Feb 20, 2014

Reduction of pacemaker implantation rates after CoreValve® implantation by moderate predilatation

Lange P, Greif M, Vogel A, Thaumann A, Helbig S, Schwarz F, Schmitz C, Becker C, D’Anastasi M, Boekstegers P, Pohl T, Laubender R, Steinbeck G, Kupatt C

free

10.4244/EIJV9I10A196 • Feb 20, 2014

Transcatheter treatment for refractory angina with the coronary sinus Reducer

Konigstein M, Meyten N, Verheye S, Schwartz M, Banai S

free

10.4244/EIJV9I10A197 • Feb 20, 2014

Relationship between initial treatment strategy and quality of life in patients with coronary chronic total occlusions

Wijeysundera H, Norris C, Fefer P, Galbraith P, Knudtson M, Wolff R, Wright G, Strauss B, Ko D

free

10.4244/EIJV9I10A198 • Feb 20, 2014

Predictors of contrast-induced nephropathy in chronic total occlusion percutaneous coronary intervention

Lin Y-S, Fang H-Y, Hussein H, Fang C-Y, Chen Y-L, Hsueh S-K, Cheng C-I, Yang C-H, Chen C-J, Hang C-L, Yip H-K, Wu C-J

free